A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications

Diabetologia

Volumn 57, Issue 1, 2014, Pages 4-15

  Fadini, G P ^a,b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

Atherosclerosis; Bone marrow; Endothelium; Regeneration; Review; Stem cells

Indexed keywords

BLOOD VESSEL INJURY; BONE MARROW CELL; CELL POPULATION; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; MACROPHAGE; MONOCYTE; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; STEM CELL NICHE; VASCULAR SURGERY;

ATHEROSCLEROSIS; BONE MARROW CELLS; DIABETES COMPLICATIONS; HUMANS; STEM CELLS;

EID: 84891034893     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3087-6     Document Type: Review

References (127)

1. Avogaro A, de Kreutzenberg SV, Fadini G (2008) Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract 82(Suppl 2):S94-S101
2. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625
3. Schaper NC, Havekes B (2012) Diabetes: impaired damage control. Diabetologia 55:18-20
4. Ii M, Takenaka H, Asai J et al (2006) Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res 98:697-704
5. Rivard A, Silver M, Chen D et al (1999) Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154:355-363
6. Ebrahimian TG, Heymes C, You D et al (2006) NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 169:719-728
7. Hazarika S, Dokun AO, Li Y et al (2007) Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Circ Res 101:948-956
8. Sorrentino SA, Bahlmann FH, Besler C et al (2007) Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 116:163-173
9. Fadini GP, Agostini C, Avogaro A (2005) Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. Curr Diabetes Rev 1:41-58
10. Fadini GP, Sartore S, Agostini C, Avogaro A (2007) Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 30:1305-1313
11. Fadini GP, Agostini C, Avogaro A (2010) Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 209:10-17
12. Clifford DM, Fisher SA, Brunskill SJ et al (2012) Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev (2) Art. no.:CD006536. doi: 10.1002/14651858.CD006536.pub3
13. Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967
14. Fadini GP, Avogaro A (2010) Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes Obes Metab 12:570-583
15. Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110:624-637
16. Hagensen MK, Raarup MK, Mortensen MB et al (2012) Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc Res 93:223-231
17. Hagensen MK, Shim J, Thim T, Falk E, Bentzon JF (2010) Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 121:898-905
18. Wickersheim A, Kerber M, de Miguel LS, Plate KH, Machein MR (2009) Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int J Cancer 125:1771-1777
19. Desai A, Glaser A, Liu D et al (2009) Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol 29:121-127
20. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164-1169
21. Urbich C, Aicher A, Heeschen C et al (2005) Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39:733-742
22. Ohtani K, Vlachojannis GJ, Koyanagi M et al (2011) Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells. Circ Res 109:1219-1229
23. Prokopi M, Pula G, Mayr U et al (2009) Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114:723-732
24. Yoder MC, Mead LE, Prater D et al (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801-1809
25. He T, Smith LA, Harrington S et al (2004) Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 35:2378-2384
26. Giannotti G, Doerries C, Mocharla PS et al (2010) Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 55:1389-1397
27. Yoder MC (2010) Is endothelium the origin of endothelial progenitor cells? Arterioscler Thromb Vasc Biol 30:1094-1103
28. Mund JA, Estes ML, Yoder MC, Ingram DA Jr, Case J (2012) Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol 32:1045-1053
29. Tura O, Skinner EM, Barclay GR et al (2013) Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow. Stem Cells 31:338-348
30. Thebaud NB, Bareille R, Remy M et al (2010) Human progenitor-derived endothelial cells vs. venous endothelial cells for vascular tissue engineering: an in vitro study. J Tissue Eng Regen Med 4:473-484
31. Fadini GP, Agostini C, Avogaro A (2007) Endothelial progenitor cells in coronary artery disease. J Am Coll Cardiol 49:1585, author reply 1585-1586
32. Zeisberger SM, Zoller S, Riegel M et al (2010) Optimization of the culturing conditions of human umbilical cord blood-derived endothelial colony-forming cells under xeno-free conditions applying a transcriptomic approach. Genes Cells 15:671-687
33. Masuda H, Iwasaki H, Kawamoto A et al (2012) Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. Stem Cells Transl Med 1:160-171
34. Kissa K, Herbomel P (2010) Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 464:112-115
35. Albiero M, Menegazzo L, Fadini GP (2010) Circulating smooth muscle progenitors and atherosclerosis. Trends Cardiovasc Med 20:133-140
36. Hagensen MK, Shim J, Falk E, Bentzon JF (2011) Flanking recipient vasculature, not circulating progenitor cells, contributes to endothelium and smooth muscle in murine allograft vasculopathy. Arterioscler Thromb Vasc Biol 31:808-813
37. Delewi R, Andriessen A, Tijssen JG et al (2013) Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials. Heart 99:225-232
38. Jeevanantham V, Butler M, Saad A et al (2012) Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126:551-568
39. Fisher SA, Doree C, Brunskill SJ, Mathur A, Martin-Rendon E (2013) Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: a systematic review and meta-analysis. PLoS One 8:e64669
40. Kandala J, Upadhyay GA, Pokushalov E et al (2013) Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. Am J Cardiol 112:217-225
41. Fadini GP (2008) An underlying principle for the study of circulating progenitor cells in diabetes and its complications. Diabetologia 51:1091-1094
42. Fadini GP, Pucci L, Vanacore R et al (2007) Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 50:2156-2163
43. Fadini GP, Miorin M, Facco M et al (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45:1449-1457
44. Fadini GP, Boscaro E, de Kreutzenberg S et al (2010) Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 33:1097-1102
45. Fadini GP, Sartore S, Albiero M et al (2006) Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26:2140-2146
46. Fadini GP, Maruyama S, Ozaki T et al (2010) Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One 5:e11488
47. + cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis 207:213-219
48. Tepper OM, Galiano RD, Capla JM et al (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786
49. Loomans CJ, de Koning EJ, Staal FJ et al (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195-199
50. Hortenhuber T, Rami-Mehar B, Satler M et al (2013) Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care 36:1647-1653
51. Dessapt C, Karalliedde J, Hernandez-Fuentes M et al (2010) Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care 33:875-877
52. Brunner S, Schernthaner GH, Satler M et al (2009) Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Invest Ophthalmol Vis Sci 50:392-398
53. Palombo C, Kozakova M, Morizzo C et al (2011) Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc Diabetol 10:88
54. Sibal L, Aldibbiat A, Agarwal SC et al (2009) Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 52:1464-1473
55. Egan CG, Lavery R, Caporali F et al (2008) Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. Diabetologia 51:1296-1305
56. Fadini GP, Agostini C, Sartore S, Avogaro A (2007) Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 194:46-54
57. Choi JH, Kim KL, Huh W et al (2004) Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24:1246-1252
58. Reinhard H, Jacobsen PK, Lajer M et al (2011) Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy. Nephron Clin Pract 118:c309-c314
59. Makino H, Okada S, Nagumo A et al (2009) Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy. Diabet Med 26:171-173
60. Fadini GP, Sartore S, Baesso I et al (2006) Endothelial progenitor cells and the diabetic paradox. Diabetes Care 29:714-716
61. - cells in patients with proliferative diabetic retinopathy. Exp Eye Res 91:229-237
62. Asnaghi V, Lattanzio R, Mazzolari G et al (2006) Increased clonogenic potential of circulating endothelial progenitor cells in patients with type 1 diabetes and proliferative retinopathy. Diabetologia 49:1109-1111
63. Brunner S, Hoellerl F, Schmid-Kubista KE et al (2011) Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular disease. Invest Ophthalmol Vis Sci 52:4655-4662
64. Liu X, Li Y, Liu Y et al (2010) Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol 176:504-515
65. Butler JM, Guthrie SM, Koc M et al (2005) SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 115:86-93
66. Jeong JO, Kim MO, Kim H et al (2009) Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 119:699-708
67. Naruse K, Hamada Y, Nakashima E et al (2005) Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 54:1823-1828
68. Rohde E, Malischnik C, Thaler D et al (2006) Blood monocytes mimic endothelial progenitor cells. Stem Cells 24:357-367
69. Asakage M, Tsuno NH, Kitayama J et al (2006) Early-outgrowth of endothelial progenitor cells can function as antigen-presenting cells. Cancer Immunol Immunother 55:708-716
70. Urbich C, Heeschen C, Aicher A et al (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108:2511-2516
71. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122:787-795
72. Mantovani A, Locati M (2013) Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol 33:1478-1483
73. Tan K, Lessieur E, Cutler A (2013) Macrophages and chemokines as mediators of angiogenesis. Front Physiol 4:159
74. Jetten N, Verbruggen S, Gijbels MJ et al (2013) Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. doi: 10.1007/s10456-013-9381-6
75. Venneri MA, de Palma M, Ponzoni M et al (2007) Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109:5276-5285
76. He H, Xu J, Warren CM et al (2012) Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages. Blood 120:3152-3162
77. Loomans CJ, van Haperen R, Duijs JM et al (2009) Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia. Mol Med 15:152-159
78. Fadini GP, Albiero M, Boscaro E et al (2010) Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells. Cell Biol Int 34:709-715
79. Bories G, Caiazzo R, Derudas B et al (2012) Impaired alternative macrophage differentiation of peripheral blood mononuclear cells from obese subjects. Diab Vasc Dis Res 9:189-195
80. Satoh N, Shimatsu A, Himeno A et al (2010) Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 33:e7
81. Fadini GP, de Kreutzenberg SV, Boscaro E et al (2013) An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia 56:1856-1866
82. Fadini GP, Cappellari R, Mazzucato M et al (2013) Monocyte-macrophage polarization balance in pre-diabetic individuals. Acta Diabetologica. doi: 10.1007/s00592-013-0517-3
83. Fadini GP, Albiero M, Menegazzo L et al (2012) Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. Exp Diabetes Res 2012:921685
84. Cui Y, Madeddu P (2011) The role of chemokines, cytokines and adhesion molecules in stem cell trafficking and homing. Curr Pharm Des 17:3271-3279
85. Hristov M, Weber C (2009) Progenitor cell trafficking in the vascular wall. J Thromb Haemost 7(1):31-34
86. Gossl M, Modder UI, Gulati R et al (2010) Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J 31:2909-2914
87. Flammer AJ, Gossl M, Li J et al (2012) Patients with an HbA1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers. J Clin Endocrinol Metab 97:4761-4768
88. Gossl M, Khosla S, Zhang X et al (2012) Role of circulating osteogenic progenitor cells in calcific aortic stenosis. J Am Coll Cardiol 60:1945-1953
89. Gossl M, Modder UI, Atkinson EJ, Lerman A, Khosla S (2008) Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol 52:1314-1325
90. Flammer AJ, Gossl M, Widmer RJ et al (2012) Osteocalcin positive CD133+/CD34-/KDR + progenitor cells as an independent marker for unstable atherosclerosis. Eur Heart J 33:2963-2969
91. Fadini GP, Rattazzi M, Matsumoto T, Asahara T, Khosla S (2012) Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation 125:2772-2781
92. Fadini GP, Albiero M, Menegazzo L et al (2011) Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res 108:1112-1121
93. Albiero M, Rattazzi M, Menegazzo L et al (2013) Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression. Basic Res Cardiol 108:368
94. Hellings WE, Peeters W, Moll FL et al (2010) Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 121:1941-1950
95. Ehara S, Kobayashi Y, Yoshiyama M et al (2004) Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 110:3424-3429
96. Menegazzo L, Albiero M, Millioni R et al (2013) Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression. FASEB J. doi: 10.1096/fj.12-223719
97. Kato K, Yonetsu T, Kim SJ et al (2012) Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv 5:1150-1158
98. Abaci A, Oguzhan A, Kahraman S et al (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99:2239-2242
99. Fadini GP (2013) A diseased bone marrow fuels atherosclerosis in diabetes. Atherosclerosis 226:337-338
100. van Ark J, Moser J, Lexis CP et al (2012) Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. Diabetologia 55:2501-2512
101. Fledderus JO, van Oostrom O, de Kleijn DP et al (2013) Increased amount of bone marrow-derived smooth muscle-like cells and accelerated atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis 226:341-347
102. Yu H, Stoneman V, Clarke M et al (2011) Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler Thromb Vasc Biol 31:1291-1299
103. Bentzon JF, Sondergaard CS, Kassem M, Falk E (2007) Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 116:2053-2061
104. Bentzon JF, Weile C, Sondergaard CS et al (2006) Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 26:2696-2702
105. Fadini GP, Tjwa M (2010) A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. Atherosclerosis 211:32-35
106. Imamura H, Ohta T, Tsunetoshi K et al (2010) Transdifferentiation of bone marrow-derived endothelial progenitor cells into the smooth muscle cell lineage mediated by tansforming growth factor-beta1. Atherosclerosis 211:114-121
107. Westerweel PE, van Velthoven CT, Nguyen TQ et al (2010) Modulation of TGF-beta/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model. Cardiovasc Diabetol 9:55
108. Nguyen TQ, Chon H, van Nieuwenhoven FA et al (2006) Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling? Diabetologia 49:1039-1048
109. Zheng F, Cornacchia F, Schulman I et al (2004) Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors. Diabetes 53:2420-2427
110. Menegazzo L, Albiero M, Avogaro A, Fadini GP (2012) Endothelial progenitor cells in diabetes mellitus. Biofactors 38:194-202
111. Fadini GP (2011) Is bone marrow another target of diabetic complications? Eur J Clin Invest 41:457-463
112. Fadini GP, Sartore S, Schiavon M et al (2006) Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49:3075-3084
113. Ferraro F, Lymperi S, Mendez-Ferrer S et al (2011) Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 3:104ra101
114. Fadini GP, Avogaro A (2013) Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease: a meta-regression analysis. Int J Cardiol 168:892-897
115. Fadini GP, Albiero M, Vigili de Kreutzenberg S et al (2013) Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 36:943-949
116. Oikawa A, Siragusa M, Quaini F et al (2010) Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol 30:498-508
117. Spinetti G, Cordella D, Fortunato O et al (2013) Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway. Circ Res 112:510-522
118. Mangialardi G, Katare R, Oikawa A et al (2013) Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway. Arterioscler Thromb Vasc Biol 33:555-564
119. Fadini GP, Avogaro A (2013) Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond. Atherosclerosis 229:23-29
120. Esposito K, Maiorino MI, Di Palo C et al (2011) Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes-a randomized controlled trial. Diabetes Obes Metab 13:439-445
121. Zhao CT, Wang M, Siu CW et al (2012) Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress. Cardiovasc Diabetol 11:147
122. Hazra S, Jarajapu YP, Stepps V et al (2013) Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia 56:644-653
123. Orlandi A, Chavakis E, Seeger F et al (2010) Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 105:703-712
124. Westerweel PE, Teraa M, Rafii S et al (2013) Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. PLoS One 8:e60357
125. Fadini GP, Albiero M, Seeger F et al (2013) Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. Basic Res Cardiol 108:313
126. Busik JV, Tikhonenko M, Bhatwadekar A et al (2009) Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med 206:2897-2906
127. Ling L, Shen Y, Wang K et al (2012) Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One 7:e50739